Trial investigators reported 35 events of pancreatitis in each treatment arm in 63 patients ( 33 [ 0.40 % ] in the saxagliptin arm and 30 [ 0.37 % ] in control arm ) , with a hazard ratio ( HR ) of 1.09 ( 95 % CI 0.66-1 .79 , P = 0.80 ) .